Literature DB >> 10416581

Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

M van Hogerlinden1, B L Rozell, L Ahrlund-Richter, R Toftgård.   

Abstract

The Rel/nuclear factor-kappaB (Rel/NF-kappaB) transcription factors have been implicated previously in control of apoptosis, cell proliferation, and oncogenesis. Here we show that selective inhibition of Rel/NF-kappaB signaling in murine skin, by targeted overexpression of a super-repressor form of IkappaB-alpha, results in an increased basal frequency of apoptotic cells and the spontaneous development of squamous cell carcinomas. Presence of hyperplasia and hair follicle degeneration demonstrate an important role for Rel/NF-kappaB signaling in normal epidermal development and homeostasis. Transgenic skin, in addition, showed an enhanced sensitivity to UV-induced apoptosis. These data suggest an involvement of the Rel/NF-kappaB signaling pathway in apoptosis and cancer development of the skin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416581

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  79 in total

1.  Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.

Authors:  I Plo; D Lautier; T Levade; H Sekouri; J P Jaffrézou; G Laurent; A Bettaïeb
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Activation of the transforming growth factor beta pathway in bacterial otitis media.

Authors:  Yun-Woo Lee; Yunju Chung; Steven K Juhn; Youngki Kim; Jizhen Lin
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-03       Impact factor: 1.547

3.  Phospholipase Cdelta1 is required for skin stem cell lineage commitment.

Authors:  Yoshikazu Nakamura; Kiyoko Fukami; Haiyan Yu; Kei Takenaka; Yuki Kataoka; Yuji Shirakata; Shin-Ichi Nishikawa; Koji Hashimoto; Nobuaki Yoshida; Tadaomi Takenawa
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

Review 4.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

Review 5.  Role of IKKα in skin squamous cell carcinomas.

Authors:  Eunmi Park; Bigang Liu; Xiaojun Xia; Feng Zhu; Willette-Brown Jami; Yinling Hu
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

Review 6.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

7.  Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization.

Authors:  Erik R Vandermark; Krysta A Deluca; Courtney R Gardner; Daniel F Marker; Cynthia N Schreiner; David A Strickland; Katelynn M Wilton; Sumona Mondal; Craig D Woodworth
Journal:  Virology       Date:  2012-01-28       Impact factor: 3.616

8.  Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation.

Authors:  Bach-Cuc Nguyen; Karine Lefort; Anna Mandinova; Dario Antonini; Vikram Devgan; Giusy Della Gatta; Maranke I Koster; Zhuo Zhang; Jian Wang; Alice Tommasi di Vignano; Jan Kitajewski; Giovanna Chiorino; Dennis R Roop; Caterina Missero; G Paolo Dotto
Journal:  Genes Dev       Date:  2006-04-15       Impact factor: 11.361

Review 9.  Keratinocyte apoptosis in epidermal development and disease.

Authors:  Deepak Raj; Douglas E Brash; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

10.  miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.

Authors:  Jian Zhou; Ying Zhang; Zhaofeng Han; Zhiwei Dong; Tongtong Cao; Aizhou Wei; Pengfei Guo; Qingnan Meng
Journal:  Cell Cycle       Date:  2019-01-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.